Phase I/II trial of the combination of midostaurin (PKC412) and 5‐azacytidine for patients with acute myeloid leukemia and myelodysplastic syndrome
暂无分享,去创建一个
M. Konopleva | Z. Estrov | M. Andreeff | H. Kantarjian | G. Garcia-Manero | J. Cortes | T. Kadia | F. Ravandi | G. Borthakur | N. Daver | M. Levis | A. Nazha | P. Strati | T. Rajkhowa | M. Durand